Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Mar;65(3):882–889. doi: 10.1128/iai.65.3.882-889.1997

Reactivity with a specific epitope of outer surface protein A predicts protection from infection with the Lyme disease spirochete, Borrelia burgdorferi.

W T Golde 1, J Piesman 1, M C Dolan 1, M Kramer 1, P Hauser 1, Y Lobet 1, C Capiau 1, P Desmons 1, P Voet 1, D Dearwester 1, J C Frantz 1
PMCID: PMC175064  PMID: 9038292

Abstract

The response to recombinant vaccines for Lyme disease was studied to determine serum antibody levels effective in protecting against tick-transmitted infection. Data presented here demonstrate a significant correlation between antibody to an epitope on outer surface protein A (OspA) and protection against infection with Borrelia burgdorferi in canines and mice. A competitive enzyme-linked immunosorbent assay was developed to measure antibody to a site on OspA, defined by monoclonal antibody LA-2. Comparison of LA-2 titers against infection of canines and mice following vaccination and challenge established a predicted value for LA-2 titers. The statistical relationship between serum antibody levels and protection was calculated by logistic regression analysis. The statistical model predicted that an LA-2 titer of 0.32 microg equivalents (eq) per ml correlated to an 80% predicted probability of protection for both mice and dogs. This value was used to classify mice and dogs as to their protected status at the time of tick exposure. The LA-2 cutoff titer (0.32 microg eq/ml) correctly classified all dogs (n = 13) and mice (n = 44) that failed to become infected. By contrast, 20 of 22 dogs and 28 of 31 mice with titers of less than 0.32 microg eq/ml became infected. On the basis of these results, we conclude that an LA-2 titer is a reliable indicator of immune status for estimating immune protection following use of OspA-based vaccines for B. burgdorferi sensu stricto.

Full Text

The Full Text of this article is available as a PDF (111.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Appel M. J., Allan S., Jacobson R. H., Lauderdale T. L., Chang Y. F., Shin S. J., Thomford J. W., Todhunter R. J., Summers B. A. Experimental Lyme disease in dogs produces arthritis and persistent infection. J Infect Dis. 1993 Mar;167(3):651–664. doi: 10.1093/infdis/167.3.651. [DOI] [PubMed] [Google Scholar]
  2. Aydintug M. K., Gu Y., Philipp M. T. Borrelia burgdorferi antigens that are targeted by antibody-dependent, complement-mediated killing in the rhesus monkey. Infect Immun. 1994 Nov;62(11):4929–4937. doi: 10.1128/iai.62.11.4929-4937.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barbour A. G., Tessier S. L., Todd W. J. Lyme disease spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody. Infect Immun. 1983 Aug;41(2):795–804. doi: 10.1128/iai.41.2.795-804.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Barthold S. W., Fikrig E., Bockenstedt L. K., Persing D. H. Circumvention of outer surface protein A immunity by host-adapted Borrelia burgdorferi. Infect Immun. 1995 Jun;63(6):2255–2261. doi: 10.1128/iai.63.6.2255-2261.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bockenstedt L. K., Fikrig E., Barthold S. W., Kantor F. S., Flavell R. A. Inability of truncated recombinant Osp A proteins to elicit protective immunity to Borrelia burgdorferi in mice. J Immunol. 1993 Jul 15;151(2):900–906. [PubMed] [Google Scholar]
  6. Burkot T. R., Wirtz R. A., Luft B., Piesman J. An OspA antigen-capture enzyme-linked immunosorbent assay for detecting North American isolates of Borrelia burgdorferi in larval and nymphal Ixodes dammini. J Clin Microbiol. 1993 Feb;31(2):272–278. doi: 10.1128/jcm.31.2.272-278.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dressler F., Whalen J. A., Reinhardt B. N., Steere A. C. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis. 1993 Feb;167(2):392–400. doi: 10.1093/infdis/167.2.392. [DOI] [PubMed] [Google Scholar]
  8. Falco R. C., Fish D. Prevalence of Ixodes dammini near the homes of Lyme disease patients in Westchester County, New York. Am J Epidemiol. 1988 Apr;127(4):826–830. doi: 10.1093/oxfordjournals.aje.a114865. [DOI] [PubMed] [Google Scholar]
  9. Fikrig E., Barthold S. W., Kantor F. S., Flavell R. A. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science. 1990 Oct 26;250(4980):553–556. doi: 10.1126/science.2237407. [DOI] [PubMed] [Google Scholar]
  10. Fikrig E., Telford S. R., 3rd, Barthold S. W., Kantor F. S., Spielman A., Flavell R. A. Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice. Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5418–5421. doi: 10.1073/pnas.89.12.5418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fikrig E., Telford S. R., 3rd, Wallich R., Chen M., Lobet Y., Matuschka F. R., Kimsey R. B., Kantor F. S., Barthold S. W., Spielman A. Vaccination against Lyme disease caused by diverse Borrelia burgdorferi. J Exp Med. 1995 Jan 1;181(1):215–221. doi: 10.1084/jem.181.1.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gern L., Rais O., Capiau C., Hauser P., Lobet Y., Simoen E., Voet P., Pêtre J. Immunization of mice by recombinant OspA preparations and protection against Borrelia burgdorferi infection induced by Ixodes ricinus tick bites. Immunol Lett. 1994 Mar;39(3):249–258. doi: 10.1016/0165-2478(94)90166-x. [DOI] [PubMed] [Google Scholar]
  13. Golde W. T., Burkot T. R., Piesman J., Dolan M. C., Capiau C., Hauser P., Dequesne G., Lobet Y. The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi. Vaccine. 1995 Apr;13(5):435–441. doi: 10.1016/0264-410x(94)00027-k. [DOI] [PubMed] [Google Scholar]
  14. Johnson B. J., Sviat S. L., Happ C. M., Dunn J. J., Frantz J. C., Mayer L. W., Piesman J. Incomplete protection of hamsters vaccinated with unlipidated OspA from Borrelia burgdorferi infection is associated with low levels of antibody to an epitope defined by mAb LA-2. Vaccine. 1995 Aug;13(12):1086–1094. doi: 10.1016/0264-410x(95)00035-y. [DOI] [PubMed] [Google Scholar]
  15. Kramer M. D., Schaible U. E., Wallich R., Moter S. E., Petzoldt D., Simon M. M. Characterization of Borrelia burgdorferi associated antigens by monoclonal antibodies. Immunobiology. 1990 Nov;181(4-5):357–366. doi: 10.1016/S0171-2985(11)80504-8. [DOI] [PubMed] [Google Scholar]
  16. Piesman J. Dynamics of Borrelia burgdorferi transmission by nymphal Ixodes dammini ticks. J Infect Dis. 1993 May;167(5):1082–1085. doi: 10.1093/infdis/167.5.1082. [DOI] [PubMed] [Google Scholar]
  17. Piesman J., Mather T. N., Sinsky R. J., Spielman A. Duration of tick attachment and Borrelia burgdorferi transmission. J Clin Microbiol. 1987 Mar;25(3):557–558. doi: 10.1128/jcm.25.3.557-558.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Piesman J., Maupin G. O., Campos E. G., Happ C. M. Duration of adult female Ixodes dammini attachment and transmission of Borrelia burgdorferi, with description of a needle aspiration isolation method. J Infect Dis. 1991 Apr;163(4):895–897. doi: 10.1093/infdis/163.4.895. [DOI] [PubMed] [Google Scholar]
  19. Plikaytis B. D., Holder P. F., Pais L. B., Maslanka S. E., Gheesling L. L., Carlone G. M. Determination of parallelism and nonparallelism in bioassay dilution curves. J Clin Microbiol. 1994 Oct;32(10):2441–2447. doi: 10.1128/jcm.32.10.2441-2447.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Schaible U. E., Kramer M. D., Eichmann K., Modolell M., Museteanu C., Simon M. M. Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice. Proc Natl Acad Sci U S A. 1990 May;87(10):3768–3772. doi: 10.1073/pnas.87.10.3768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Schaible U. E., Wallich R., Kramer M. D., Gern L., Anderson J. F., Museteanu C., Simon M. M. Immune sera to individual Borrelia burgdorferi isolates or recombinant OspA thereof protect SCID mice against infection with homologous strains but only partially or not at all against those of different OspA/OspB genotype. Vaccine. 1993;11(10):1049–1054. doi: 10.1016/0264-410x(93)90132-h. [DOI] [PubMed] [Google Scholar]
  22. Shih C. M., Pollack R. J., Telford S. R., 3rd, Spielman A. Delayed dissemination of Lyme disease spirochetes from the site of deposition in the skin of mice. J Infect Dis. 1992 Oct;166(4):827–831. doi: 10.1093/infdis/166.4.827. [DOI] [PubMed] [Google Scholar]
  23. Shih C. M., Spielman A., Telford S. R., 3rd Short report: mode of action of protective immunity to Lyme disease spirochetes. Am J Trop Med Hyg. 1995 Jan;52(1):72–74. doi: 10.4269/ajtmh.1995.52.72. [DOI] [PubMed] [Google Scholar]
  24. Simon M. M., Schaible U. E., Kramer M. D., Eckerskorn C., Museteanu C., Müller-Hermelink H. K., Wallich R. Recombinant outer surface protein a from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice. J Infect Dis. 1991 Jul;164(1):123–132. doi: 10.1093/infdis/164.1.123. [DOI] [PubMed] [Google Scholar]
  25. Stover C. K., Bansal G. P., Hanson M. S., Burlein J. E., Palaszynski S. R., Young J. F., Koenig S., Young D. B., Sadziene A., Barbour A. G. Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine. J Exp Med. 1993 Jul 1;178(1):197–209. doi: 10.1084/jem.178.1.197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Telford S. R., 3rd, Fikrig E., Barthold S. W., Brunet L. R., Spielman A., Flavell R. A. Protection against antigenically variable Borrelia burgdorferi conferred by recombinant vaccines. J Exp Med. 1993 Aug 1;178(2):755–758. doi: 10.1084/jem.178.2.755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Wang H., Nuttall P. A. Excretion of host immunoglobulin in tick saliva and detection of IgG-binding proteins in tick haemolymph and salivary glands. Parasitology. 1994 Nov;109(Pt 4):525–530. doi: 10.1017/s0031182000080781. [DOI] [PubMed] [Google Scholar]
  28. Wilske B., Barbour A. G., Bergström S., Burman N., Restrepo B. I., Rosa P. A., Schwan T., Soutschek E., Wallich R. Antigenic variation and strain heterogeneity in Borrelia spp. Res Microbiol. 1992 Jul-Aug;143(6):583–596. doi: 10.1016/0923-2508(92)90116-6. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES